| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Canada | 8 | |
| #2 | EPO (European Patent Office) | 8 | |
| #3 | Republic of Korea | 6 | |
| #4 | United States | 5 | |
| #5 | China | 4 | |
| #6 | Israel | 4 | |
| #7 | Mexico | 4 | |
| #8 | Norway | 4 | |
| #9 | South Africa | 4 | |
| #10 | Australia | 3 | |
| #11 | Brazil | 3 | |
| #12 | EAPO (Eurasian Patent Organization) | 3 | |
| #13 | Japan | 3 | |
| #14 | WIPO (World Intellectual Property Organization) | 3 | |
| #15 | Latvia | 2 | |
| #16 | New Zealand | 2 | |
| #17 | Singapore | 2 | |
| #18 | Georgia | 1 | |
| #19 | Taiwan | 1 | |
| #20 | Ukraine | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Measurement | |
| #3 | Biotechnology | |
| #4 | Agriculture | |
| #5 | Machines | |
| #6 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Analysing materials | |
| #4 | Microorganisms | |
| #5 | Animal care | |
| #6 | Peptides | |
| #7 | Unspecified technologies | |
| #8 | Unspecified technologies | |
| #9 | Heterocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Lichter Jay | 48 |
| #2 | Mata Nathan L | 46 |
| #3 | Widder Kenneth | 40 |
| #4 | Han Yun | 13 |
| #5 | Jay Lichter | 5 |
| #6 | Widder Ken | 5 |
| #7 | Phan Kim B | 4 |
| #8 | Bui Tam V | 4 |
| #9 | Kenneth Widder | 4 |
| #10 | Haddach Mustapha | 3 |
| Publication | Filing date | Title |
|---|---|---|
| US2009253745A1 | Modulators of ocular oxidative stress | |
| WO2009042444A2 | Methods and compounds for treating retinol-related diseases | |
| JP2008007518A | Method, assay and composition for treating retinol-associated disease | |
| MX2008016167A | Methods and compositions for treating ophthalmic conditions via modulation of megalin activity. | |
| ZA200708091B | Methods, assays and compositions for treating retinol-related diseases | |
| EP1807103A2 | Modulators of retinol-retinol binding protein (rbp)-transthyretin (ttr) complex formation | |
| EP1804788A2 | Detection and analysis of ophthalmically-relevant fluorescent molecules | |
| EP2025336A1 | Retinyl derivatives for treating ophtalmic conditions | |
| CN1976692A | Methods and compositions for treating ophthalmic conditions with retinyl derivates |